Biological monitoring of the ethylene oxide gas effects on medical utilities sterilization exposed staff

Yıl 2011, Cilt: 16 Sayı: 1, 44 - 52, 21.01.2013

Mahmoud M. Kamel Mahmoud A. İ. Hewehy Ahmed H. M. Hussein Waleed Samy

Öz

Abstract. Chronic exposure to Ethylene Oxide (EtO) gas was suggested to be associated with many health hazards. This study was conducted on thirty one workers exposed to EtO gas in different production areas and classified into three groups; group I included seven workers with direct exposure, group II included thirteen workers with partial exposure and group III included eleven workers with indirect exposure. One group included 20 non exposed persons and served as a control group (group IV). All of them underwent analysis of complete blood count, T-lymphocytes subsets (CD3, CD4, CD8) by flowcytometery technique, serum IgG concentration by ELISA technique and p53 gene mutational changes. Platelet count was significantly reduced in all exposed groups. Both CD3% and CD4% were significantly decreased in group I and II (p≤0.05, p≤0.001) respectively. Also, the absolute value of T-helper lymphocytes was significantly reduced in group I and II (p≤0.05). However, CD8% was significantly increased only in group III (p≤0.05). A significant elevated value of total IgG was found in group I and II (p≤0.05). Variable gene mutation was detected in p53 exons (5b, 6 and 7) which were 28.5% (group I), 7.7% (group II) and 9% (group III) for exon 5b, 28.5% (group I) and 15.4% (group II) for exon 6 and 14.2% (group I), 7.7% (group II) and 9% (group III) for exon -7. There was significant reduced platelet count in all exposed groups. Both CD3% and CD4% and the absolute value of T-helper lymphocytes were significantly reduced in group I and II. EtO gas exposed personals showed a remarked IgG concentrations increments. There were genetically observed mutational changes located at p53 gene post EtO gas exposure.

Key words: Ethylene oxide gas chronic exposure, T-lymphocytes subsets (CD3, CD4, CD8), p53 gene mutation

Anahtar Kelimeler

Ethylene oxide gas chronic exposure, T-lymphocytes subsets (CD3, CD4, CD8), p53 gene mutation

Kaynakça

• Lee C, John K, Mark F, Barbara C. Hemoglobin adducts and sister chromatid in hospital workers exposed to ethylene oxide: Effects of glutathione-s-transferase T1 and M1 genotypes. Cancer epidemiology biomarkers and prevention 2001; 10: 539- 550.
• Scholla AJ, Watkins WD, Guess WL. Comparative chemical and toxicological evaluation of residual ethylene oxide in sterilized plastics. J Pharm Sci 2006; 58: 1007-1010.
• Fennell TR, Brown CD. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human. Toxicol Appl Pharmacol 2001; 173: 161-175.
• Thier R, Bolt HM. Carcinogenicity and genotoxicity of ethylene oxide: new aspects and recent advances. Crit Rev Toxicol 2000; 30: 595-608.
• Kolman A, Chovanec M, Osterman-Golkar S. Genotoxic effects of ethylene oxide, propylene oxide and epichlorohydrin in humans: update review (1990-2001). Mutat Res 2002; 512: 173-194.
• Romaguera C, Vilaplana J. Airborne occupational contact dermatitis from ethylene oxide. Contact Dermatitis J 1997; 11: 39-85.
• Ahlborg G Jr, Hemminki K. Reproductive effects of chemical exposures in health professions. J Occup Environ Med 1995; 37: 957-961.
• Nancy SV, Heuser SG. Ethylene oxide and its persistent reaction products in wheat flour and other Commodities: residues from fumigation or sterilization, and effects of processing. J Pestic Sci 2007; 2: 80-91.
• Wolfs P, Dutrieux M, Scailteur V, et al. Surveillance des travailleurs exposes à l'oxyde d'éthylène dans une entreprise de distribution de gaz stérilisants et dans des unités de stérilisation de matériel médical. Arch Mal Prof 1999; 44: 321-328.
• Yong LC, Schulte PA, Wiencke JK, et al. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S- transferase T1 and M1 genotypes. Cancer Epidemiol Biomarkers Prev 2001; 10: 539- 550.
• Boogaard PJ. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 778: 309-322.
• Burgaz S, Rezanko R, Kara S, Karakaya AE. Thioethers in urine of sterilization personnel exposed to ethylene oxide. J Clin Pharm Ther 1992; 17: 169-172.
• Potter R, Jorkasky JF. Engineering control of Ethylene Oxide exposures from gas sterilization in the safe use of Ethylene Oxide: proceedings of the educational seminar. Health Industry Manufacturers Association 2000; 80: 193-208.
• Anonymous. Guide to occupational exposure values. Cincinnati 2006; ACGIH: pp. 58-88.
• Vincent H, Brigitte M, Annette H, et al. Exposure to Ethylene Oxide in hospitals: Biological monitoring and influence of glutathione-S transferase and epoxide hydrolase polymorphisms. Cancer Epidemiology, Biomarkers& Prevention 2007; 16: 796-804.
• National Institute for Occupational Safety and Health (NIOSH). Manual of analytical methods 1994; http: // www. cdc.gov / niosh / nmam.
• Occupational Safety and Health Administration (OSHA). Occupational Health and Safety Standards 2004; (1910.1047): Ethylene Oxide, www. osha. gov.
• Warbrick EV, Dearman RJ, Kimber I. IgG and IgE antibody responses following exposure of Brown Norway rats to trimellitic anhydride: comparison of inhalation and topical exposure. Toxicology 2002; 172: 157- 168.
• Frederick M, Roger B, David D, et al. Current protocols in molecular biology 2nd Edition. John Wiley & Sons, Inc 2003.
• March G, Hirose T, Goldstein R, Bailey C. The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells. Ann N Y Acad Sci 2006; 59: 757-805.
• WHO. Ethylene Oxide and Environmental Health Criteria, IPCS, International Programme on Chemical Safety Geneva 1985; 55.
• Schulte PA, Walker JA, Boeniger MF, Tsuchiya Y, Halperin WE. Molecular, cytogenetic, and hematologic effects of Ethylene Oxide on female hospital workers. J Occup Environ Med 1995; 37: 313-320.
• Santoro F, Tates AD, Grunnt T, et al. Biological chemical monitoring of occupational exposure to ethylene oxide. Mutate Res 2007; 250: 483-497.
• Luoping Z, Craig S, David A. Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms; a comparable study with other industrial sterilizing gases. J Mut Rev 2008; 4: 55-60.
• Tryphonas H. Approaches to detecting immunotoxic effects of environmental contaminants in humans. Environ Health Perspect 2001; 109: 877-884.
• Lars H, Tom B, Benkt H, et al. Biological effects in a chemical factory with mutagenic exposure: cytogenetic and hematological parameters. Int Ach Ocup Environ Health 1988; 60: 437-444.
• Van Sittert NJ, de Jong G, Clare MG, et al. Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant. Br J Ind Med 1985; 42: 19-26.
• Tompa A, Jakab M, Biró A, et al. Chemical safety and health conditions among Hungarian hospital nurses. Ann N Y Acad Sci 2006; 1076: 635-648.
• Christopher D, Thai-Vu T, Natasha C, et al. Frequent p53 and H-ras mutations in Benzene and Ethylene Oxide induced mammary gland carcinomas from B6C3F1 mice. Toxicological Pathology 2006; 34: 752-762.
• Debbie A, Donland J, Robert G, et al. Dose- response relationships for N7-(2- hydroxyl ethyl) guanine induced by low dose C14 ethylene oxide: evidence for a novel mechanism of endogenous adduct formation. J Cancer Research 2009; 69: 52-62.
• Lu F, Segal A, Solomon JJ. In vitro reaction of Ethylene Oxide with DNA and characterization of DNA adducts. Chem Biol Interact 2001; 83: 35-54.
• Gen T, Ken S, Chihaya M, et al. Alterations in adenoma and differentiated adenocarcinoma of the stomach1 microsatellite. J Cancer Research 1995; 55: 1933-1936.
• Coggon D, Harris EC, Poole J, Palmer KT. Mortality of workers exposed to ethylene oxide: extended follow up of a British cohort. Occup Environ Med 2004; 61: 358-362.
• http://www.epa.gov/ttn/atw/eo/eopg.html.
• international agency for research on cancer. Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Industrial Chemicals, 1999; Volume 60: p 4.